首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance
【24h】

UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance

机译:基于UHPLC / Q-TOFMS的多囊卵巢综合征患者胰岛素抵抗与非胰岛素抵抗的血浆代谢组学

获取原文
获取原文并翻译 | 示例
           

摘要

Polycystic ovary syndrome (PCOS), characterized with menstrual irregularities, hyperandrogenism and ovulatory abnormalities, is usually companied with insulin resistance (IR) and accounts for one of the most prevalent reproductive dysfunction of premenopausal women. Despite accumulating investigations, diagnostic standards of this pathological condition remain obscure. The aim of present study is to characterize the plasma metabolic characteristics of PCOS patients with and without IR, and subsequently identify the potential biomarkers for the diagnosis of PCOS and its IR complication. A total of 59 plasma samples from eligible healthy controls (CON, n=19), PCOS patients without IR (non-IR PCOS, n=19) and PCOS patients with IR (IR PCOS, n=21) were profiled by an ultra high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC/Q-TOFMS) followed by multivariate statistical analysis. Compared to the healthy controls, significant decrease in the levels of phosphocholines (PCs) and lyso PC (18:2), and increase in trilauric glyceride level were observed in the plasma of IR PCOS. Meanwhile, the significant increase in the levels of saturated fatty acids (palmitic acid and stearic acid) and decanoylcarnitine, and decrease in PC (36:2) and PS (36:0) were found in non-IR PCOS patients. Trilauric glyceride and decanoylcarnitine were identified as the potential biomarkers with the highest sensitivity and specificity for the diagnosis of PCOS patients with and without IR, respectively. Furthermore, based on these alterations of metabolites, MetPA network pathway analysis suggested a profound involvement of the abnormalities of glycerophospholipid, glycerolipid and fatty acid metabolisms in the pathogenesis of PCOS and IR complications. Collectively, LC-MS-based metabolomics provides a promising strategy for complementary diagnosis of PCOS and its IR complication and offers a new insight to understand their pathogenesis mechanisms. (C) 2016 Elsevier B.V. All rights reserved.
机译:多囊卵巢综合征(PCOS)具有月经不调,雄激素过多和排卵异常,通常伴有胰岛素抵抗(IR),是绝经前女性最普遍的生殖功能障碍之一。尽管进行了越来越多的研究,但这种病理状况的诊断标准仍然不清楚。本研究的目的是表征患有和不患有IR的PCOS患者的血浆代谢特征,并随后鉴定出诊断PCOS及其IR并发症的潜在生物标志物。通过超声对来自合格健康对照者(CON,n = 19),无IR的PCOS患者(非IR PCOS,n = 19)和有IR的PCOS患者(IR PCOS,n = 21)的总共59个血浆样品进行了分析高效液相色谱-四极杆飞行时间质谱(UHPLC / Q-TOFMS),然后进行多元统计分析。与健康对照组相比,在IR PCOS血浆中观察到磷胆碱(PCs)和溶血PC(18:2)的水平显着降低,三月桂酸甘油酯水平升高。同时,在非IR PCOS患者中,饱和脂肪酸(棕榈酸和硬脂酸)和癸酰肉碱的含量显着增加,PC(36:2)和PS(36:0)降低。三月桂酸甘油酯和癸酰肉碱被确定为潜在的生物标志物,分别对诊断和不诊断IR的PCOS患者具有最高的敏感性和特异性。此外,基于这些代谢物的变化,MetPA网络途径分析表明,甘油磷脂,甘油脂和脂肪酸代谢异常与PCOS和IR并发症的发病机理密切相关。总的来说,基于LC-MS的代谢组学为PCOS及其IR并发症的互补诊断提供了一种有前途的策略,并为了解其发病机理提供了新的见解。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号